Logo image of ALESA.PA

ECOSLOPS (ALESA.PA) Stock Fundamental Analysis

EPA:ALESA - Euronext Paris - Matif - FR0011490648 - Common Stock - Currency: EUR

0.532  -0.01 (-1.48%)

Fundamental Rating

3

Taking everything into account, ALESA scores 3 out of 10 in our fundamental rating. ALESA was compared to 46 industry peers in the Commercial Services & Supplies industry. While ALESA seems to be doing ok healthwise, there are quite some concerns on its profitability. ALESA has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ALESA had negative earnings in the past year.
In the past year ALESA has reported a negative cash flow from operations.
ALESA had negative earnings in each of the past 5 years.
In the past 5 years ALESA reported 4 times negative operating cash flow.
ALESA.PA Yearly Net Income VS EBIT VS OCF VS FCFALESA.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -2M -4M -6M -8M -10M

1.2 Ratios

The Return On Assets of ALESA (-11.00%) is worse than 78.26% of its industry peers.
The Return On Equity of ALESA (-40.65%) is worse than 76.09% of its industry peers.
ALESA's Return On Invested Capital of 4.01% is in line compared to the rest of the industry. ALESA outperforms 50.00% of its industry peers.
Industry RankSector Rank
ROA -11%
ROE -40.65%
ROIC 4.01%
ROA(3y)-10.7%
ROA(5y)-9.36%
ROE(3y)-37.88%
ROE(5y)-30.98%
ROIC(3y)N/A
ROIC(5y)N/A
ALESA.PA Yearly ROA, ROE, ROICALESA.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 -20 -40 -60 -80

1.3 Margins

Looking at the Operating Margin, with a value of 12.20%, ALESA belongs to the top of the industry, outperforming 86.96% of the companies in the same industry.
Looking at the Gross Margin, with a value of 66.24%, ALESA is in the better half of the industry, outperforming 73.91% of the companies in the same industry.
In the last couple of years the Gross Margin of ALESA has grown nicely.
Industry RankSector Rank
OM 12.2%
PM (TTM) N/A
GM 66.24%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y14.36%
ALESA.PA Yearly Profit, Operating, Gross MarginsALESA.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -100 -200

More info and screens

4

2. Health

2.1 Basic Checks

Compared to 1 year ago, ALESA has about the same amount of shares outstanding.
ALESA has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ALESA has remained at the same level compared to a year ago.
ALESA.PA Yearly Shares OutstandingALESA.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M 5M
ALESA.PA Yearly Total Debt VS Total AssetsALESA.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

2.2 Solvency

ALESA has an Altman-Z score of -0.83. This is a bad value and indicates that ALESA is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ALESA (-0.83) is worse than 76.09% of its industry peers.
ALESA has a Debt/Equity ratio of 2.05. This is a high value indicating a heavy dependency on external financing.
ALESA has a worse Debt to Equity ratio (2.05) than 71.74% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.05
Debt/FCF N/A
Altman-Z -0.83
ROIC/WACCN/A
WACCN/A
ALESA.PA Yearly LT Debt VS Equity VS FCFALESA.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M

2.3 Liquidity

ALESA has a Current Ratio of 2.66. This indicates that ALESA is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of ALESA (2.66) is better than 82.61% of its industry peers.
A Quick Ratio of 2.32 indicates that ALESA has no problem at all paying its short term obligations.
ALESA has a better Quick ratio (2.32) than 84.78% of its industry peers.
Industry RankSector Rank
Current Ratio 2.66
Quick Ratio 2.32
ALESA.PA Yearly Current Assets VS Current LiabilitesALESA.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

More info and screens

5

3. Growth

3.1 Past

ALESA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 45.04%, which is quite impressive.
ALESA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -30.36%.
The Revenue has been growing slightly by 6.62% on average over the past years.
EPS 1Y (TTM)45.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.15%
Revenue 1Y (TTM)-30.36%
Revenue growth 3Y21.29%
Revenue growth 5Y6.62%
Sales Q2Q%11.45%

3.2 Future

The Earnings Per Share is expected to grow by 57.96% on average over the next years. This is a very strong growth
ALESA is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 59.18% yearly.
EPS Next Y55.5%
EPS Next 2Y57.96%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year60.53%
Revenue Next 2Y59.18%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALESA.PA Yearly Revenue VS EstimatesALESA.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
ALESA.PA Yearly EPS VS EstimatesALESA.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0.5 -0.5 -1

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

ALESA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 1.04, the valuation of ALESA can be described as very cheap.
100.00% of the companies in the same industry are more expensive than ALESA, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.10, ALESA is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 1.04
ALESA.PA Price Earnings VS Forward Price EarningsALESA.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALESA.PA Per share dataALESA.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5 2

4.3 Compensation for Growth

ALESA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALESA's earnings are expected to grow with 57.96% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y57.96%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALESA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ECOSLOPS

EPA:ALESA (3/7/2025, 7:00:00 PM)

0.532

-0.01 (-1.48%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)09-26 2024-09-26
Earnings (Next)04-30 2025-04-30/amc
Inst Owners12.56%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.76M
Analysts86.67
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 1.04
P/S 0.25
P/FCF N/A
P/OCF N/A
P/B 0.34
P/tB 0.41
EV/EBITDA N/A
EPS(TTM)-0.63
EYN/A
EPS(NY)0.51
Fwd EY95.84%
FCF(TTM)-0.39
FCFYN/A
OCF(TTM)-0.29
OCFYN/A
SpS2.1
BVpS1.54
TBVpS1.28
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11%
ROE -40.65%
ROCE 5.51%
ROIC 4.01%
ROICexc 5.9%
ROICexgc 6.42%
OM 12.2%
PM (TTM) N/A
GM 66.24%
FCFM N/A
ROA(3y)-10.7%
ROA(5y)-9.36%
ROE(3y)-37.88%
ROE(5y)-30.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y14.36%
F-Score5
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 2.05
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 4.54%
Interest Coverage 0.75
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.66
Quick Ratio 2.32
Altman-Z -0.83
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)45.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.15%
EPS Next Y55.5%
EPS Next 2Y57.96%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-30.36%
Revenue growth 3Y21.29%
Revenue growth 5Y6.62%
Sales Q2Q%11.45%
Revenue Next Year60.53%
Revenue Next 2Y59.18%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y133.5%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year440%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-32.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-542.94%
OCF growth 3YN/A
OCF growth 5YN/A